DRW Venture Capital invests in biotech companies at the Series A stage, focusing on nurturing early-stage firms with support for growth and innovation. They leverage deep expertise in global trading and investment, utilizing technology and research for informed decisions. DRW balances startup excitement with the stability of an established firm. Employees tackle engaging problems and are rewarded for achievements within a culture that values continuous learning, collaboration, and high expectations. Notable investments include DelSiTech.
